CDC flags increase in stomach bug that’s becoming 'extensively drug-resistant'

Norge Nyheter Nyheter

CDC flags increase in stomach bug that’s becoming 'extensively drug-resistant'
Norge Siste Nytt,Norge Overskrifter
  • 📰 KTVU
  • ⏱ Reading Time:
  • 79 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 53%

It’s called shigellosis, and comes from easily-spread bacteria that are proving to be more and more resistant to antibiotics.

Colonial morphology of Shigella boydii bacteria cultivated on a Hektoen enteric agar surface, 1976. Image courtesy Centers for Disease Control . that it has been monitoring an increase in a particular stomach bug that’s becoming increasingly resistant to antibiotic intervention.

A shigella infection, called shigellosis, brings about diarrhea that lasts for several days, usually up to a week, and possibly also fever and stomach cramps. It is caused by bacteria that spreads easily, typically through person-to-person contact including sexual contact, and indirectly through contaminated food and water.

The CDC estimates that shigella cause about 450,000 diarrheal illnesses, 5,400 hospitalizations, and 40 deaths each year in the United States. And now a strain that has become "extensively drug-resistant,"Figure: Percentage of Shigella isolates that showed an extensively drug resistant phenotype or genotype in the United States, by year, 2015–2022. infections reported to the CDC were caused by extensively drug-resistant strains, compared with none in 2015.

But on Feb. 24, the CDC said it has observed an increase in antimicrobial-resistant infections among the following adult populations in particular: International travelersSymptoms in some cases can last more than a month. And in further cases, it may take several months before bowel habits return to normal.

, shigellosis can cause complications including reactive arthritis, bloodstream infections, seizures, or hemolytic-uremic syndrome , a kidney complication most commonly seen in child patients. to give further information to healthcare providers about diagnosis and managing the XDR strain infections since they are difficult to treat. As of now, the CDC does not have recommendations for any antimicrobial treatment of XDR strains.

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

KTVU /  🏆 465. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Flu shot provided 'substantial protection' this season, CDC says | CNNFlu shot provided 'substantial protection' this season, CDC says | CNNThe 2022-2023 flu shot reduced the risk of flu-related hospitalization by nearly three quarters among children andby nearly half among adults, according to new data from the US Centers for Disease Control and Prevention. Vaccinated adults were also about half as likely to have flu-related illness and emergency department visits.
Les mer »

Flu shot provided ‘substantial protection’ this season, CDC saysFlu shot provided ‘substantial protection’ this season, CDC saysThe 2022-2023 flu shot reduced the risk of flu-related hospitalization by nearly three quarters among children and by nearly half among adults.
Les mer »

Did CDC Raise 'Lethal Exposure' Level of Vinyl Chloride Days Before Ohio Train Derailment?Did CDC Raise 'Lethal Exposure' Level of Vinyl Chloride Days Before Ohio Train Derailment?'I'm not a conspiracy theorist,' said one tweet, 'but why did the CDC update their profile for vinyl chloride 11 DAYS before the train crash in Ohio?'
Les mer »

This season's flu vaccine provided 'substantial protection' across all age groups, CDC saysThis season's flu vaccine provided 'substantial protection' across all age groups, CDC saysThe flu shot provided 'substantial protection' for all age groups, including elderly and immunocompromised populations, during this influenza season, the CDC reported.
Les mer »

Not enough data to support multiple annual COVID boosters, U.S. CDC advisers sayNot enough data to support multiple annual COVID boosters, U.S. CDC advisers sayThere is not sufficient evidence to recommend more than one COVID-19 booster shot a year for older people and those with weakened immune systems, an expert advisory group to the U.S. Centers for Disease Control and Prevention (CDC) said on Friday.
Les mer »

CDC advisory group finds insufficient evidence to recommend more than one COVID-19 booster a yearCDC advisory group finds insufficient evidence to recommend more than one COVID-19 booster a yearA working committee for the U.S. Centers for Disease Control and Prevention found insufficient evidence to recommend more than one yearly COVID-19 booster.
Les mer »



Render Time: 2025-03-06 09:15:56